Target intelligence / Profile preview

Dengue virus NS2B-NS3 serine protease (NS2B/NS3 protease)

Target
NS2B/NS3 protease
Molecular classification
Enzyme, Serine protease, Viral protease
01

Overview

The **Dengue virus NS2B-NS3 serine protease** is a two-component viral enzyme essential for dengue virus replication, composed of the NS3 protease domain and its cofactor, the membrane-associated NS2B region[1][5][7]. This protease is responsible for cleaving the viral polyprotein at several nonstructural sites, enabling the production of functional viral proteins necessary for genome replication and assembly[5][6][7]. The enzyme is anchored to the endoplasmic reticulum via transmembrane helices of NS2B and requires the active participation of both NS2B and NS3 regions for catalytic activity[1][7]. Because of its central role in the viral lifecycle and absence in human cells, it is a primary therapeutic target in dengue drug development efforts, with both active-site and allosteric inhibitors being explored as potential antiviral agents[4][6][8].

Other names
Dengue virus proteaseDENV NS2B/NS3 proteaseNS2B-NS3 proteaseFlaviviral NS2B/NS3 protease
02

Mechanism of action

Active-site inhibition (orthosteric): competitive inhibition by small molecules or peptides binding at the active site, blocking substrate access[1][6] Allosteric inhibition: small molecules (e.g., curcumin) bind to secondary sites, altering the enzyme conformation and preventing activation[4][8]

03

Biological functions

Viral polyprotein processingViral replicationViral assemblyInhibition of host innate immunity
04

Disease associations

Infection
05

Safety considerations

High sequence conservation in NS2B/NS3 across flaviviruses poses a risk of off-target effects on beneficial host pathways if inhibitors are not highly specific[6]Resistance development due to viral mutation (escape variants)[3]Drug delivery and cell permeability, as protease is associated with ER membranes and intracellular
06

Interacting drugs

Aprotinin (bovine pancreatic trypsin inhibitor)[1][6]

3 more in the full profile.

07

Biomarkers

No validated clinical biomarkers; research uses viral RNA titers, viral protein levels, and in vitro protease activity as functional readouts in experimental settings[5]

Beyond the preview

Go deeper on Dengue virus NS2B-NS3 serine protease (NS2B/NS3 protease).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue virus NS2B-NS3 serine protease (NS2B/NS3 protease).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call